Guo Hao Jin
Direttore/Membro del Consiglio presso Beijing Advaccine Biotechnology Co., Ltd.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Bin Wang | M | 66 |
Beijing Advaccine Biotechnology Co., Ltd.
 Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 15 anni |
| Qing Ling Yu | F | 58 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 15 anni |
| Wen Wei Tu | M | 57 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 3 anni |
| Jian Qun Peng | F | 39 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 anni |
| Lu Nan Zhang | F | 36 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 7 anni |
| Guan Chun Dai | M | 47 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 3 anni |
| Xiao Yan Liu | M | 40 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 anni |
| Gan Zhao | M | 44 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 9 anni |
| Hong Qin | F | 57 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 3 anni |
| Dan Liu | M | 50 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 anni |
| Ai Hua Dong | F | 57 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 9 anni |
| Guo Tong Xu | M | 67 |
Tongji University
| 16 anni |
| Zhou Lu | F | 52 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 12 anni |
| Ji Ma | M | 62 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | - |
| Shui Li Yu | M | 62 |
Tongji University
| 14 anni |
| Wai Ching Au | F | - |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | - |
| Zhi Yun Yu | M | 45 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 anni |
| Xue Qin Wu | F | 51 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 anni |
| Xiao Hu Dai | M | 61 |
Tongji University
| 14 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Jianxun Wang | M | 45 |
Tongji University
| 3 anni |
| Wan Peng He | M | 50 |
Tongji University
| 3 anni |
| Dong Wang | M | 41 |
Tongji University
| 1 anni |
| Xue Cao | F | 33 |
Tongji University
| 4 anni |
| Chen Jian Chu | M | 40 |
Tongji University
| 4 anni |
| Li Chao Hao | M | 38 |
Tongji University
| 4 anni |
| Teng Zhou | M | 56 |
Tongji University
| 2 anni |
| Jianan Jiang | M | 39 |
Tongji University
| 3 anni |
| Kai Cai Ge | M | 42 |
Tongji University
| 1 anni |
| Yi Gang Xu | M | 50 |
Tongji University
| 1 anni |
| Li Min Wang | M | 49 |
Tongji University
| 4 anni |
| Yan Guo | F | 36 |
Tongji University
| 4 anni |
| Xi Wei | M | 39 |
Tongji University
| 1 anni |
| Zhi Sen Yu | M | 41 |
Tongji University
| 2 anni |
| Qi Huang | M | 41 |
Tongji University
| 1 anni |
| Zhuang Kang | M | 33 |
Tongji University
| 4 anni |
| Jiacheng Li | M | 43 |
Tongji University
| 2 anni |
| Shu Yang Fan | M | 40 |
Tongji University
| 4 anni |
| Gui Fa Zhou | M | 61 |
Tongji University
| 3 anni |
| Hong Bin Ding | M | 57 |
Tongji University
| 3 anni |
| Zhen Yu Liu | M | 52 |
Tongji University
| 2 anni |
| Jiang Wang | M | 53 |
Tongji University
| 2 anni |
| Jian Hua Wu | M | 45 |
Tongji University
| 4 anni |
| Yun Cai Wang | M | 56 |
Tongji University
| 6 anni |
| Tong Zhang | M | 64 |
Tongji University
| 4 anni |
| Xiao Xing Song | M | 43 |
Tongji University
| 3 anni |
| Xing Yue Liao | M | 42 |
Tongji University
| 3 anni |
| Sophie Zhu | F | - |
Tongji University
| 5 anni |
| Xiao Chen | M | 39 |
Tongji University
| 4 anni |
| Jian Jun Dong | M | 56 |
Tongji University
| 2 anni |
| Jia Fang Jin | M | 46 |
Tongji University
| 2 anni |
| Tong Chen | M | 38 |
Tongji University
| 4 anni |
| Chun Chun Du | M | 39 |
Tongji University
| 4 anni |
| Jian Liang | M | 43 |
Tongji University
| 2 anni |
| Ling Wei Lu | M | 47 |
Tongji University
| 1 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Cina | 54 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Guo Hao Jin
- Contatti personali
